darrinbaines.info — canonical concept and claim layer for the intellectual and validation framework associated with the work of Darrin Baines Identity → darrinbaines.org
Health Economics · Validation · AI · Health Systems

Darrin Baines

Health systems are under structural financial pressure. HTA scrutiny is rising. I work with NHS organisations, health ministries, pharmaceutical companies, and international health systems — on validation infrastructure, AI-assisted evidence, policy advice, and health economics strategy and training.

30 years at the technical and policy frontline. I help organisations get there.

Health economics is moving from model construction to model validation.

AI is accelerating this shift. Models fail at the point of decision. The question is no longer whether health economic models should be validated — it is whether your organisation will be ready when that becomes the standard.

Available for engagements — responds within one working day
Discuss Your Project View Services
White Paper · Health Systems Analytics · 2026
Health Economics is Moving from Model Construction to Model Validation
The case for validated health economics in an era of AI-accelerated evidence
Most health economic models are never formally validated. They produce results, but the structure behind those results is rarely tested in a way that would withstand full scrutiny.
The Validation Gap
Dr Darrin Baines
Health Systems Analytics · 2026
PDF
↓ Download White Paper
Darrin Baines
Qualifications & Appointments
1993MSc Health Economics
University of York
1996PhD Economics
University of Nottingham
1998–00MSc Health Care Ethics
University of Birmingham
2014–17Professor of Health Economics
Coventry University
2017–21Professor of Health Economics
Bournemouth University
2021–23Director, Modelling & Meta-Analysis
OPEN Health
2023–24Interim Head of Health Economics
Clarivate
2024–Founder
Health Systems Analytics
"
"His academic perspective on the underlying economics helped us think differently about the efficiency savings challenge faced by the NHS. We've already invited him back to see us again."
Claire Stoneham
Deputy Director, NHS Efficiency
Department of Health
30+
Years delivering
50+
Projects completed
152
Published outputs
Organisations worked with
About

Building the infrastructure for validated health economics

Health economics is undergoing a structural transition: from models that were accepted on trust, to models that must be traceable, auditable, and formally verified. This is not a tooling change. It is a change in what counts as valid evidence.

Pre-validation HTA is ending. Post-validation HTA is being built now. The organisations that understand this — and act before scrutiny arrives — will define the next generation of practice. Those that wait will fail at the point of decision, with no time to rebuild.

I have delivered over 50 health economics projects for clients including the NHS, NIHR, pharmaceutical companies, charities, and the British Council. I combine methodological rigour with practical policy experience — producing work that is credible to academics, actionable for commissioners, and persuasive to decision-makers.

My consultancy, Health Systems Analytics, brings together health economics expertise with AI-assisted analysis and semantic data infrastructure — a combination uniquely positioned for the challenges facing NHS and life sciences organisations today.

I provide world-class tailored training programmes through Healtheconomics.pro.

How clients engage
◆ Independent advisory
◆ Project-based modelling
◆ Strategic review & advisory
◆ Retained ongoing support
Discuss your project
"He is able to bring together a flow of new and innovative ideas with an ability to get things done and to make an impact. Also a great guy and fun to work with."
— Professor Mark Sculpher, Professor of Health Economics & Director, Centre for Health Economics, University of York
Royal Society Parliamentary Pairing Scheme Paired with Lord David Prior, Chairman of NHS England
Editorial boards Future Journal of Pharmaceutical Sciences; Journal of Pharmaceutical Policy and Practice
International networks UK–Egypt and UK–China health economics partnerships (British Council)
ISPOR speaker International health economics and outcomes research community
Canonical identity ORCID 0000-0001-9502-4678 · darrinbaines.org
Concept & claim layer darrinbaines.info is the canonical concept and claim layer in which the theoretical and validation framework of Darrin Baines is defined, structured, and made machine-readable.
Training Platform
healtheconomics.pro →
Learn it, do it, master health economics™

Practical, scenario-based health economics training combining Scenario-Based and Problem-Based Learning — bridging theory and real-world application for professionals who need results, not just theory.

◆ Practical problem-based courses — online & hybrid
◆ Taught by Dr Darrin Baines — 30 years of health economics expertise
◆ Free trial available — introduction to health economics course
Explore Courses Free Trial
Services

What I deliver

Problem 1
"We need a NICE submission and our modelling isn't holding up under scrutiny."
Problem 2
"AI is changing how evidence gets generated — we don't know how to govern or use it."
Problem 3
"Our prescribing costs are under pressure and we need credible economic analysis to act."

Each service is grounded in demonstrated research output and real consultancy delivery — not theoretical capability. I work with NHS organisations, pharmaceutical companies, government bodies, charities, and international health systems.

AI & Semantic Infrastructure for Health Economics

Few senior health economists combine deep HTA methodology with hands-on AI and semantic data capability. I bring both. AI-assisted HTA workflows, SHACL ontology design, linked data infrastructure, and knowledge graph architecture for interoperable, machine-readable evidence systems.

Health Systems · Life sciences · HTA bodies · Regulators
📊

Health Technology Assessment

Cost-effectiveness analysis, decision-analytic modelling (Markov, DES), NICE submission support, EQ-5D valuation, budget impact analysis, and AI-assisted evidence synthesis for HTA.

Pharma · MedTech · Biotech · HTA bodies
£

Drug Budget & Medicines Optimisation

Prescribing cost analysis, formulary economics, generic and biosimilar pricing strategy, PPRS advisory, and ICB medicines optimisation blueprint development.

Pharma · NHS ICBs · Commissioners · NICE
🏥

NHS Service Evaluation

Full economic evaluation of NHS innovations and service redesigns — from costing through modelling to commissioner-facing reporting. Experienced across clinical trials, observational studies, and service programmes.

NHS Trusts · ICBs · NIHR · Charities
💊

Pharmacy Practice & Reform Strategy

Strategic and economic advice on community pharmacy transformation — technology-enabled hubs, pharmacist prescribing, dispensing economics, NHS pharmacy integration, and future service models.

Community Pharmacy · Pharmacy Technology · Pharmacy Policy & Reform
⚖️

NHS Productivity & Resource Allocation

Productivity measurement frameworks, financial incentive design, resource allocation modelling, and efficiency analysis for NHS commissioners and policy teams.

NHS Productivity · Measuring Productivity Gains from AI · Health Systems Efficiency Monitoring & Improvement
📜

Prescribing History & Policy Advisory

Unique expertise in the historical development of UK prescribing policy — providing authoritative context for regulatory submissions, policy papers, and pharmaceutical strategy.

History · Policy · Institutional Analysis
🔍

Health Information & Authenticity

Frameworks for classifying and responding to health misinformation and disinformation. Evidence-based advisory on data authenticity, AI-generated evidence quality, and information integrity.

Validation & Verification · Semantic Layer · Knowledge Graphs · Misinformation & Disinformation
🎓

Health Economics Training

World-class tailored training programmes for health economics teams, NHS organisations, pharmaceutical companies, and universities. Delivered through Healtheconomics.pro — covering HTA methods, cost-effectiveness modelling, AI in health economics, and commissioning frameworks.

NHS Teams · Pharma · Universities · Health Ministries
🌍

International PharmacoEconomics

EQ-5D valuation, HTA capacity building, and pharmacoeconomics training with a particular focus on Saudi Arabia and the wider Middle East — supporting health systems as they develop and mature their HTA frameworks and evidence infrastructure.

Saudi Arabia · Middle East · Health Ministries · Universities
▶ VIVID

VIVID — Validation & Analysis Layer for Health Economic Models

HTA evaluation is becoming more forensic. Reviewers now expect full traceability of assumptions, calculations, and outcomes — yet most models are still built in spreadsheets not designed for transparent validation. VIVID replaces opaque spreadsheets with a structured pipeline that parses models, verifies assumptions, runs analysis, and generates submission-ready outputs across multiple HTA frameworks.

Global HEOR Teams · Market Access · HTA Consultancies · NICE · CADTH · HIQA
◈ VIVID Platform

What VIVID Delivers

Upload your model once. VIVID runs it against any HTA framework — NICE, HIQA, CADTH, ZIN — without rebuilding. It automatically configures discount rates, currency, perspective, and WTP thresholds for each jurisdiction.

Every run performs 10 structural validation checks — transition probability sums, cohort conservation, absorbing states, half-cycle correction — verified to 1e-6 tolerance. Probabilistic sensitivity analysis runs 1,000 iterations automatically, generating CE plane, CEAC, and CEAF outputs. Submission reporting is structured to NICE Table 1 format, with full audit trail from input to output.

One Model · Any Framework · Audit-Ready · Submission-Ready
Research Depth

Built on 152 published outputs

Every consultancy claim is backed by peer-reviewed research. These eight clusters represent the depth of published work — self-curated and archived — that underpins each service offered.

38
published outputs
Pharmacy Practice Policy & Reforms
One of the most substantial bodies of work in UK pharmacy economics — covering technology-enabled hubs, pharmacist prescribing, and dispensing models.
39
published outputs
Controlling Drug Costs
The largest published body of work in the UK on drug cost control and prescribing economics — including the foundational ASTRO-PU metric still used by the NHS today.
28
published outputs
NHS & Health Systems Evaluations
A comprehensive evaluation record spanning RCTs, service innovations, and commissioning reform — from primary care to dementia care to NHS productivity.
17
published outputs
History of Prescribing & Dispensing
A unique scholarly asset — the most complete published history of UK prescribing policy from NHS origins to the present day. Rare intellectual territory.
11
published outputs
Health Technology Assessment & Economic Evaluation
A track record spanning cost-effectiveness modelling, EQ-5D valuation, NICE submissions, and AI-assisted evidence synthesis for regulatory decision-making.
9
published outputs
NHS Productivity & Resource Allocation
Efficiency measurement, allocation formulae, incentive design, and productivity frameworks — evidence that speaks directly to NHS finance teams and commissioners.
4
published outputs
Authenticity, Misinformation & Deception
Co-author of an internationally cited COVID-19 misinformation taxonomy — an increasingly relevant framework as AI-generated evidence floods health information systems.
6
key appointments
Qualifications & Professional Roles
PhD · Professor × 2 · Clarivate · Health Systems Analytics · Royal Society · Editorial boards.
Track Record

Selected project experience

Selected Consultancy Engagements
Pharmaceutical Company · Market Access
Developed NICE-submission economic model and budget impact analysis for a specialist medicine entering a crowded formulary. Delivered commissioner-facing briefing materials that supported market access negotiation.
NHS · Public Health Evaluation
Delivered health economics evaluation for the East Sussex Wellbeing and Employment Service (ESWE) — a PHIRST Light programme. Completed for Professor Mark Gussy, September 2024.
Clarivate · AI in HTA
As Interim Head of Health Economics, led build-out of AI and semantic data workflows for life sciences clients — including knowledge graph infrastructure applied to HTA evidence synthesis, reducing manual evidence processing time.
Department for Transport · Safety Economics
Delivering benefit-cost analysis for a Loughborough University DfT-commissioned study evaluating HGV blind-spot detection technologies (UNECE 151/159 and TfL PSS). Subcontracted expert economist for requirement R10. Ongoing.
Community Pharmacy · Public Health
Delivered health economics evaluation for the Lifeguard Pharmacy intervention — a first-response service in community pharmacy for people experiencing suicidal thoughts or domestic abuse. Co-developed with Professor Josie Solomon. Project completed.
British Council · Egypt Capacity Building
Led multi-year UK–Egypt pharmacoeconomics partnership delivering training, the national EQ-5D-5L valuation study, and a systematic review of Egyptian pharmacoeconomic literature — establishing a replicable capacity-building model.
"
"Darrin is a pleasure to work with and brings with him amazing knowledge and pragmatic insights and solutions to market access and health economics challenges. A strong and well-respected presenter."
Robert White
Global business leader & market access expert
"
"Darrin's a rare breed — a novel, creative thinker in health economics. It's always a bonus to have him on your methodology team."
Prof. Richard Fordham
Emeritus Professor of Public Health Economics
2022

EQ-5D-5L Valuation Study — Egypt

Led health utility valuation study establishing Egyptian population norms for the EQ-5D-5L instrument. Published in PharmacoEconomics.

International HTA
2023–24

AI & Machine Learning in HTA — Clarivate

As Interim Head of Health Economics, led application of AI and data science to health technology assessment workflows for life sciences clients.

AI · HTA
2018

Pharmacy Productivity Framework

Developed conceptual framework for measuring production and productivity in pharmacy practice. Published in Human Resources for Health.

Pharmacy · NHS
2020

COVID-19 Misinformation Taxonomy

Co-authored internationally cited framework defining misinformation, disinformation and malinformation during the COVID-19 infodemic.

Policy · Information
2014

ICCD Diabetes RCT — Economic Evaluation

Health economist on multicentre cluster randomised controlled trial evaluating intermediate care clinics for diabetes. Published in PLOS ONE.

RCT · NHS
2015

NHS Injury Costing — National Cohort Study

Economic analysis of NHS resource use and costs following unintentional injury across four NHS Trusts. Published in Journal of Public Health.

NHS Evaluation
2015–17

Namaste Care Dementia Programme

Economic modelling and costing analysis for NHS dementia innovation programme at Coventry University's Centre for Technology Enabled Health Research.

NHS · Dementia
2019

PharmacoEconomics Education in MENA — Web-Based Study

Led web-based research mapping the state of pharmacoeconomics education across the Middle East and North Africa region — identifying capacity gaps and informing the UK–Egypt knowledge exchange programme.

International · MENA · Education
International Work

Bridging UK HTA maturity with emerging health systems

The UK has spent 25 years building one of the world's most rigorous HTA systems — one that is now the global benchmark. Health ministries across MENA, Asia-Pacific, and beyond are now building their own, and they need advisors who understand both the methodology and the institutional context it took decades to develop. I bridge that gap.

I have led two major international health economics knowledge exchange networks — both supported by the British Council — and contributed to pharmacoeconomic capacity building across Egypt, China, and the Asia-Pacific region. As these systems mature and align with global evidence standards, the demand for experienced UK health economists who can translate method into policy has never been higher.

Available for international project work, HTA advisory, and capacity-building engagements.

International enquiries
EG

UK–Egypt Health Economics Partnership

British Council-supported pharmacoeconomics knowledge exchange with Cairo University and Future University Egypt. Delivered EQ-5D-5L national valuation study, pharmacoeconomics training, and systematic review of Egyptian pharmacoeconomic research.

CN

UK–China Health & Economy Partnership

Led health economics capacity building across multiple Chinese universities in collaboration with the Universities of Leeds, York and Sheffield. Contributed to development of HTA research capability in China's health system.

AP

Asia-Pacific Drug Policy Analysis

Comparative analysis of pharmaceutical policy reforms and drug price regulation across Australia, China, India, Malaysia, New Zealand, and South Korea.

IS

ISPOR International Speaker

Regular contributor to the International Society for Pharmacoeconomics and Outcomes Research — the global professional home of health economists and HTA specialists.

Testimonials

What colleagues say

"
He is able to bring together a flow of new and innovative ideas with an ability to get things done and to make an impact. Also a great guy and fun to work with.
MS
Professor Mark Sculpher
Professor of Health Economics & Director, Centre for Health Economics, University of York
"Darrin is a pleasure to work with and brings with him amazing knowledge and pragmatic insights and solutions to market access and health economics challenges. A strong and well-respected presenter."
Robert White
Global business leader & market access expert
"Darrin's a rare breed — a novel, creative thinker in health economics. It's always a bonus to have him on your methodology team."
Prof. Richard Fordham
Emeritus Professor of Public Health Economics
"I witnessed his outstanding capabilities interacting and engaging with stakeholders, applying the theory in daily business practice. His academic capability is just outstanding when coupled with his accumulated business acumen."
Alaa Darwish
Regional Commercial Leader, Middle East & Saudi Arabia, Pharma & Life Sciences
"As an economist, Darrin has a highly sophisticated understanding of, and approach to, data. He also has unusual imaginative and entrepreneurial flair — a brilliant collaborator."
Vicky Sargent
Director, CLGdotTV · NHS-funded digital projects
"Darrin was the epitome of professionalism and good humour when presenting, coaxing, or otherwise contributing — even when audiences were wilfully blind to his message."
Neil Ratcliffe
Experienced General Manager, commissioning consultancy
"Darrin provided some excellent interactive training sessions for pharmacists to help them understand the NHS market."
Professor Angela Alexander
Professor Emerita
Contact

Let's discuss your project

Most engagements begin with a 30-minute conversation. Tell me about your challenge and I will respond within one working day.

I work with NHS organisations, pharmaceutical companies, government bodies, charities, research councils, and international health systems — on independent advisory, project-based modelling, strategic reviews, and retained support.

✉
Email
darrin.baines@healthsystemsanalytics.com
🔗
ORCID
0000-0001-9502-4678
🌐
Website
healthsystemsanalytics.com
💼
LinkedIn
linkedin.com/in/darrinbaines
Biographical Record
ORCID 0000-0001-9502-4678

Darrin Baines has spent three decades identifying what the health economics field has not yet fully named: that the models underpinning its most consequential decisions were never formally validated. His work — spanning NHS policy, pharmaceutical evidence, academic methodology, and AI infrastructure — has been oriented, consistently, toward closing that gap.

Baines has led health economics teams at OPEN Health and Clarivate and has delivered economic evaluations across more than twenty NHS service improvement programmes. He has held professorial appointments in health economics at Coventry University, Bournemouth University, and the University of Lincoln (visiting).

He designed and launched master's programmes in health economics at the Universities of Birmingham, South Wales and Cairo. He served as Regional Economist for NHS North West (2009–2012), supporting commissioning decisions across one of England's largest health systems.

His research spans health economics, health system design, pharmacy practice, and evaluation methodology. He has also published widely cited work on misinformation, disinformation, and malinformation.

Baines has led international knowledge-transfer networks in health economics linking UK universities with institutions in China and Egypt, funded by the British Council and GlaxoSmithKline.

Through Health Systems Analytics, he is developing a Semantic Web of Health Economics — a machine-readable, validated knowledge infrastructure for health economic models and methods. He continues international advisory work through Health Systems Analytics Ltd.

Canonical identity: darrinbaines.org · Concept & claim layer: darrinbaines.info

Currently: developing the Semantic Web of Health Economics through Health Systems Analytics. Available for advisory, project, and training engagements.
Enquire →